IP Library Granted Patent US 11,904,138
Granted Patent B2
US 11,904,138 · App. 17/162,042 · Granted Feb 20, 2024

Glucose level management without carbohydrate counting

Inventors: Boyi Jiang (Pasadena, CA); Yuxiang Zhong (Arcadia, CA); Pratik J. Agrawal (Porter Ranch, CA); Ali Dianaty (Porter Ranch, CA)
Assignee: Medtronic MiniMed, Inc.
A61M5/1723A61K9/0009A61K9/0019A61K38/28G16H20/60G16H50/20A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,904,138
App. No.
17/162,042
Granted
Feb 20, 2024
Kind
B2
Abstract

Disclosed herein are techniques related to glucose level management without carbohydrate counting. The techniques may involve obtaining contextual information for a meal, predicting amounts of glucose to be absorbed into a bloodstream of the patient over a duration of time due to consumption of the meal based on the contextual information for the meal, determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose, and affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

Claims (41)

1. A system for glucose level management without carbohydrate counting, the system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

obtaining contextual information for a meal;

predicting amounts of glucose to be absorbed into a bloodstream of a patient over a duration of time due to consumption of the meal based at least in part on a correlation between the contextual information for the meal and amounts of glucose absorbed into the bloodstream due to the consumption of the meal;

determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

2. The system of claim 1 , wherein the amounts of glucose to be absorbed into the bloodstream comprises a first amount of glucose to be absorbed into the bloodstream at a first time instance within the duration of time, and a second amount of glucose to be absorbed into the bloodstream at a second time instance within the duration of time.

3. The system of claim 1 , wherein the one or more processor-readable storage media further store instructions which, when executed by the one or more processors, cause performance of:

prior to predicting the amounts of glucose to be absorbed into the bloodstream, determining a second correlation between contextual information for one or more previous meals and amounts of glucose absorbed into the bloodstream of the patient over a duration of time due to consumption of the one or more previous meals, wherein determining the second correlation is performed without information from the patient relating to carbohydrates consumed from the one or more previous meals.

4. The system of claim 1 , wherein determining the one or more amounts of insulin comprises:

obtaining an insulin sensitivity factor for the patient; and

determining the one or more amounts of insulin to counteract effects of the predicted amounts of glucose based on the insulin sensitivity factor.

5. The system of claim 1 , wherein determining the one or more amounts of insulin comprises utilizing a mathematical model to predict a glycemic response of the patient based on a candidate amount of insulin and the predicted amounts of glucose to be absorbed into the bloodstream over the duration of time.

6. The system of claim 1 , wherein determining the one or more amounts of insulin comprises using an artificial intelligence technique to determine a dosage of insulin that corresponds to a maximum amount of time within a target range for the patient's glucose levels.

7. The system of claim 1 , wherein predicting the amounts of glucose to be absorbed comprises utilizing one or more of a group comprising a statistical averaging technique, a pattern matching technique, and a machine learning technique.

8. The system of claim 1 , wherein the contextual information comprises one or more of a group comprising a time of day, a day of week, and a patient location.

9. The system of claim 1 , wherein affecting the insulin therapy comprises:

communicating towards an insulin delivery device the information indicative of the determined one or more amounts of insulin.

10. The system of claim 9 , wherein the insulin delivery device is an injection device configured to automatically set an insulin level based on the information indicative of the determined one or more amounts of insulin.

11. The system of claim 9 , wherein the insulin delivery device is an insulin pump configured to automatically deliver the determined one or more amounts of insulin to the patient.

12. The system of claim 1 , wherein the one or more processors are included in one or more network devices.

13. A processor-implemented method for glucose level management without carbohydrate counting, the method comprising:

obtaining contextual information for a meal;

predicting amounts of glucose to be absorbed into a bloodstream of a patient over a duration of time due to consumption of the meal based at least in part on a correlation between the contextual information for the meal and amounts of glucose absorbed into the bloodstream due to the consumption of the meal;

determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

14. The method of claim 13 , wherein the amounts of glucose to be absorbed into the bloodstream comprises a first amount of glucose to be absorbed into the bloodstream at a first time instance within the duration of time, and a second amount of glucose to be absorbed into the bloodstream at a second time instance within the duration of time.

15. The method of claim 13 , further comprising prior to predicting the amounts of glucose to be absorbed into the bloodstream, determining a second correlation between contextual information for one or more previous meals and amounts of glucose absorbed into the bloodstream of the patient over a duration of time due to consumption of the one or more previous meals, wherein determining the second correlation is performed without information from the patient relating to carbohydrates consumed from the one or more previous meals.

16. The method of claim 13 , wherein determining the one or more amounts of insulin comprises:

obtaining an insulin sensitivity factor for the patient; and

determining the one or more amounts of insulin to counteract effects of the predicted amounts of glucose based on the insulin sensitivity factor.

17. The method of claim 13 , wherein determining the one or more amounts of insulin comprises utilizing a mathematical model to predict a glycemic response of the patient based on a candidate amount of insulin and the predicted amounts of glucose to be absorbed into the bloodstream over the duration of time.

18. The method of claim 13 , wherein predicting the amounts of glucose to be absorbed comprises utilizing one or more of a group comprising a statistical averaging technique, a pattern matching technique, and a machine learning technique.

19. The method of claim 13 , wherein affecting the insulin therapy comprises:

communicating towards an insulin delivery device the information indicative of the determined one or more amounts of insulin.

20. One or more non-transitory processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:

obtaining contextual information for a meal;

predicting amounts of glucose to be absorbed into a bloodstream of a patient over a duration of time due to consumption of the meal based at least in part on a correlation between the contextual information for the meal and amounts of glucose absorbed into the bloodstream due to the consumption of the meal;

determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2021
From: JIANG, BOYI; ZHONG, YUXIANG; AGRAWAL, PRATIK J.; DIANATY, ALI
To: MEDTRONIC MINIMED, INC.
Reel/Frame 055075/0931 →
Continuity (1)
Related Publication 20220241500A1 · Aug 4, 2022